Advertisement

Topics

Search Results for "Suppository "

16:07 EDT 23rd September 2017 | BioPortfolio

Matching Channels

None

Matching News

CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding

WOBURN, Mass., Dec. 19, 2012 /PRNewswire/ -- CutisPharma, Inc. today announced that the United States Patent and Trademark Office has issued a patent (US 8,276,757 B2) regarding a method for the ...

Cannabis Science Releases First Test Batch of Suppositories to Aid Self-Medicating Patients That Require Alternative Delivery Methods With Severe Pain and Symptoms Related to Cancers, Anxiety, and Insomnia

IRVINE, CA -- (Marketwired) -- 05/11/17 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the release of a limited b...

Cannabis Science Steps Up the Fight Against Opioid Drug Addictions with its Initial Test Batch of Transdermal Patches and Unisex Rectal Suppositories Available Now in Los Angeles Dispensaries, Meeting a Growing Demand from Self-Medicating Patients

IRVINE, CA -- (Marketwired) -- 07/07/17 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce initial test bat...

CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line

WOBURN, Mass., Dec. 21, 2011 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST® - Mouthwash BLM 4oz and FIRST® - Mouthwash BLM 6oz compounding kits. These p...

Astellas Submits Supplemental New Drug Application for Approval of Additional Indication of "Linaclotide" for Patients with Chronic Constipation in Japan

Tokyo, September 11, 2017  - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas” ) today announced that it has submitted a supplemental new drug appli...

Cannabis Science Issues Second Quarter Update Looking Forward to More Quarterly Growth and Progress Reports with More New and Exciting Revenue Developments Coming Soon

IRVINE, CA -- (Marketwired) -- 08/07/17 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to update its shareholder...

Working with kathy ireland® and Level Brands Inc., Damiva, the Taboo Breaking Women’s Health Company, Expands into Cardinal Health

Together with kathy ireland® Worldwide and Level Brands Inc., Damiva is changing the way the world thinks of women’s health over age 35. Toronto, Ontario (PRWEB) September 21, 2017 Working wit...

BioSyent Inc RX Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryBioSyent Inc BioSyent, formerly Hedley Technologies Inc is a drug manufacturing company that acquires and licenses products and technologies to enhance human health. The company's products incl...

Matching PubMed Articles

Designing and developing suppository formulations for anti-HIV drug delivery.

Despite a long history of use for rectal and vaginal drug delivery, the current worldwide market for suppositories is limited primarily due to a lack of user acceptability. Therefore, virtually no rat...

Thermosensitive In Situ Gel Based on Solid Dispersion for Rectal Delivery of Ibuprofen.

The objective of this study was to develop a thermosensitive in situ gel based on solid dispersions (SDs) for rectal delivery of ibuprofen (IBU). Thermosensitive (poloxamer 407) and mucoadhesive (hydr...

Oral gavage delivery of PR8 antigen with β-glucan conjugated GRGDS carrier to enhance M-cell targeting ability and induce immunity.

Oral gavage is known as one of most convenient routes for therapeutic administration in comparison with other available routes such as intravenous, intra muscular, suppository, etc. An oral vaccine de...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement